Finally, a significant enrichment of proviral integrations targeting some cancer-related genes, such as BACH2 and MKL2 and others, has been observed in peripheral blood mononuclear cells (PBMC) and CD4+ T lymphocytes isolated from HIV-infected individuals under combination antiretroviral therapy (cART)8–10. Here, BACH2 is linked to cancer.